The protective effect of cannabinoid type 2 receptor activation on renal ischemia–reperfusion injury

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Molecular and Cellular Biochemistry

• Publication date

  2019-08-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11010-019-03616-6PMID 31446615
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cannabinoid type 2 receptor agonist JWH‐133, attenuates Okadaic acid induced spatial memory impairment and neurodegeneration in rats

  2019cited by this paper
• Selective Cannabinoid 2 Receptor Stimulation Reduces Tubular Epithelial Cell Damage after Renal Ischemia-Reperfusion Injury

  2018cited by this paper
• Biomarkers of Sepsis-Induced Acute Kidney Injury

  2018cited by this paper
• Protective effect of N‐(p‐amylcinnamoyl) anthranilic acid, phospholipase A2 enzyme inhibitor, and transient receptor potential melastatin‐2 channel blocker against renal ischemia–reperfusion injury

  2018cited by this paper
• 8‐Br‐cADPR, a TRPM2 ion channel antagonist, inhibits renal ischemia–reperfusion injury

  2018cited by this paper
• The role of cannabinoid signaling in acute and chronic kidney diseases.

  2018cited by this paper
• Novel acute kidney injury biomarkers: their characteristics, utility and concerns

  2018cited by this paper
• Cannabinoids and the kidney: effects in health and disease.

  2017cited by this paper
• Biomarkers in acute kidney injury (AKI).

  2017cited by this paper
• Protective effects of salusin-α and salusin-β on renal ischemia/reperfusion damage and their levels in ischemic acute renal failure

  2017cited by this paper
• Increased Renal 2-Arachidonoylglycerol Level Is Associated with Improved Renal Function in a Mouse Model of Acute Kidney Injury

  2016cited by this paper
• Renal effects of chronic pharmacological manipulation of CB2 receptors in rats with diet‐induced obesity

  2016cited by this paper
• Tubular Epithelial NF-κB Activity Regulates Ischemic AKI.

  2016cited by this paper
• Anandamide and its metabolites: what are their roles in the kidney?

  2016cited by this paper
• The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI‐101 prevents cisplatin‐induced nephrotoxicity

  2016cited by this paper
• Therapy with a Selective Cannabinoid Receptor Type 2 Agonist Limits Albuminuria and Renal Injury in Mice with Type 2 Diabetic Nephropathy

  2015cited by this paper
• Minireview: From the bench, toward the clinic: therapeutic opportunities for cannabinoid receptor modulation.

  2015cited by this paper
• Renal ischemia/reperfusion injury; from pathophysiology to treatment

  2015cited by this paper
• The effect of dexmedetomidine against oxidative and tubular damage induced by renal ischemia reperfusion in rats

  2015cited by this paper
• Novel Biomarkers of Acute Kidney Injury in the General Adult ICU: A Review

  2013cited by this paper
• Activation of Cannabinoid Type 2 Receptor by JWH133 Protects Heart Against Ischemia/Reperfusion-Induced Apoptosis

  2013cited by this paper
• Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to Neuroprotection

  2012cited by this paper
• Erythropoietin ameliorates renal ischemia and reperfusion injury via inhibiting tubulointerstitial inflammation.

  2012cited by this paper
• Celebrating 25 years of NF‐κB research

  2012cited by this paper
• Risk factors for mortality in acute kidney injury.

  2011influential reference
• Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy

  2011cited by this paper
• Role for Cannabinoid Receptors in Human Proximal Tubular Hypertrophy

  2011cited by this paper
• Fatores de risco para mortalidade na lesão renal aguda

  2011cited by this paper
• Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy.

  2010cited by this paper
• Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment

  2010cited by this paper
• Netrin-1 Regulates Th1/Th2/Th17 Cytokine Production and Inflammation through UNC5B Receptor and Protects Kidney against Ischemia–Reperfusion Injury

  2010cited by this paper
• Cannabinoid receptor 1 mediates palmitic acid‐induced apoptosis via endoplasmic reticulum stress in human renal proximal tubular cells

  2010cited by this paper
• Mediators of Inflammation in Acute Kidney Injury

  2010cited by this paper
• CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model

  2010cited by this paper
• CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion.

  2009cited by this paper
• The nuclear factor NF-kappaB pathway in inflammation.

  2009cited by this paper
• Protective Effects of Pycnogenol against Ischemia Reperfusion-Induced Oxidative Renal Injury in Rats

  2009cited by this paper
• Protective effects of doxycycline in ischemia/reperfusion injury on kidney

  2009cited by this paper
• Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis.

  2009cited by this paper
• The preventive effect of cannabinoids on reperfusion-induced ischemia of mouse kidney.

  2008cited by this paper
• Community-based incidence of acute renal failure.

  2007cited by this paper
• Renal ischemia-reperfusion injury: renal dendritic cells loudly sound the alarm.

  2007cited by this paper
• Cannabinoid‐2 receptor mediates protection against hepatic ischemia/reperfusion injury

  2007cited by this paper
• The NF-κB pathway

  2005cited by this paper
• The NF-kappaB pathway.

  2005cited by this paper
• Plasma cytokine levels predict mortality in patients with acute renal failure.

  2004cited by this paper
• Pathophysiology of ischaemic acute renal failure.

  2004cited by this paper
• Cellular and molecular events underlying ischemia-induced neuronal apoptosis.

  2003cited by this paper
• Transcription factor-kappa B (NF-kappa B) and renal disease.

  2001cited by this paper
• Pharmacology of cannabinoid receptor ligands.

  1999cited by this paper
• Kidney Injury Molecule-1 (KIM-1), a Putative Epithelial Cell Adhesion Molecule Containing a Novel Immunoglobulin Domain, Is Up-regulated in Renal Cells after Injury*

  1998cited by this paper
• Production and physiological actions of anandamide in the vasculature of the rat kidney.

  1997cited by this paper
• Oxygen free radicals in ischemic acute renal failure in the rat.

  1984cited by this paper
• AUTOIMMUNE DISEASE IN NZB/BL MICE

  1966cited by this paper
• Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry Original Paper Cannabinoid Receptor 2 Expression in Human Proximal Tubule Cells Is Regulated by Albumin Independent of Erk1/2 Signaling Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry

  year unknowncited by this paper

• Agomelatine Protects Cyclophosphamide-Induced Testicular Tissue Damage Despite HPG Axis Suppression in Rats

  2026cites this paper
• To CB2 or not CB2: Revisiting renoprotection in acute and chronic kidney injury

  2025cites this paper
• Neuroprotective Effects of Bromelain on Acute Ischemic Stroke in Rats

  2025cites this paper
• Investigation of the Effects of Saxagliptin in In Vitro and In Vivo Models of Diabetic Neuropathy

  2025cites this paper
• Myrtenal Ameliorates Ischemic Brain Injury Diabetic and Non-Diabetic Rats

  2025cites this paper
• Bilateral and Unilateral Renal Ischemia‐Reperfusion Injury Model in Rats

  2025cites this paper
• Asprosin protects against ischemia/reperfusion-induced kidney injury in mice

  2025cites this paper
• Protective Effect of Transient Receptor Potential Ankyrin 1 Inhibition on Renal Ischemia Reperfusion Injury in Rats

  2025cites this paper
• Protective Effects of Phoenixin‐14 Administration Against Renal Ischemia/Reperfusion Injury in Rats

  2025cites this paper
• The intervention of cannabinoid receptor in chronic and acute kidney disease animal models: a systematic review and meta-analysis

  2024influential citation
• A highly potent, orally bioavailable pyrazole-derived cannabinoid CB2 receptor-selective full agonist for in vivo studies

  2024influential citation
• A Highly Potent, Orally Bioavailable Pyrazole-Derived Cannabinoid CB2 Receptor- Selective Full Agonist for In Vivo Studies

  2024cites this paper
• The Potential of JWH-133 to Inhibit the TLR4/NF-κB Signaling Pathway in Uterine Ischemia–Reperfusion Injury

  2024cites this paper
• Lack of Cannabinoid Type 2 Promoter Activity in Normal or Injured Kidneys Using a Cnr2-GFP Reporter Mouse

  2024cites this paper
• The effects of cannabinoids on the kidney

  2024cites this paper
• Renal Outcomes and Other Adverse Effects of Cannabinoid Supplementation

  2024cites this paper
• Role of Cannabinoid Type 2 Receptor Activation in Renal Fibrosis Induced by Unilateral Ureteric Obstruction in Rats.

  2023cites this paper
• Structural basis of selective cannabinoid CB2 receptor activation

  2023cites this paper
• Protective effect of fatty acid amide hydrolase inhibitor URB597 and monoacylglycerol lipase inhibitor KML29 on renal ischemia-reperfusion injury via toll-like receptor 4/nuclear factor-kappa B pathway.

  2023cites this paper
• Expression and Functions of the CB2 Receptor in Human Leukocytes

  2022cites this paper
• Recent Advances on Type-2 Cannabinoid (CB2) Receptor Agonists and Their Therapeutic Potential.

  2022cites this paper
• An Overview of Ischemia–Reperfusion Injury: Review on Oxidative Stress and Inflammatory Response

  2022cites this paper
• Could Lycopene Protect Against Ischemia/Reperfusion Injury in the Uterus?

  2021cites this paper
• Modulation of Endocannabinoids by Caloric Restriction Is Conserved in Mice but Is Not Required for Protection from Acute Kidney Injury

  2021cites this paper
• Activation of cannabinoid 2 receptors by JWH-133 protects against ovarian ischemia-reperfusion injury in rats

  2021cites this paper
• Investigation of the Therapeutic Effects of Chloroquine in Adriamycin-Induced Hepatotoxicity

  2021cites this paper
• Cannabinoid Type-2 Receptor Agonist, JWH133 May Be a Possible Candidate for Targeting Infection, Inflammation, and Immunity in COVID-19

  2021cites this paper
• Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist

  2021cites this paper
• Barbaloin attenuates ischemia reperfusion-induced oxidative renal injury via antioxidant and anti-inflammatory effects

  2020influential citation
• Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products

  2020cites this paper
• Preventive effects of fraxin on ischemia/reperfusion-induced acute kidney injury in rats.

  2019cites this paper